Safety and Efficacy of NAFT900 in Children With Tinea Capitis

Summary

A Double-Blind, Randomized, Vehicle-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of NAFT-900 in Children Aged 6 to \< 13 Years with Tinea Capitis

Timeline

Start

—

Primary completion

2016-07

Completion

—

Drugs

Indications